Compass Therapeutics, Inc. (CMPX) earnings per share (EPS)

Earnings per share · fiscal 2025
-$0.42

Compass Therapeutics, Inc. (CMPX) reported diluted earnings per share of -$0.42 in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$0.36. Figures as of 18 Nov 2026, 12:34 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings per share, fiscal 2025
-$0.42
Highest on record
-$0.33fiscal 2023
Lowest on record
-$0.42fiscal 2025
Fiscal years on record
42022–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Compass Therapeutics, Inc. earnings per share (EPS), in more detail

Across the 4 fiscal years on record (2022–2025), the highest was -$0.33 in fiscal 2023 and the lowest -$0.42 in fiscal 2025.

History · 4 fiscal years

Earnings per share by fiscal year

Compass Therapeutics, Inc. earnings per share (EPS), year by year

Compass Therapeutics, Inc. (CMPX) earnings per share (EPS) by fiscal year
Fiscal yearEarnings per shareChangeYear ended
2025-$0.42—
2024-$0.36—
2023-$0.33—
2022-$0.37—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

How to read it

It shows how much profit stands behind each share, so it rises when profit grows or when buybacks shrink the share count.

More on CMPX

Compass Therapeutics, Inc., figure by figure

Compass Therapeutics, Inc. (CMPX) overview: price, valuation and scorecard

Compass Therapeutics, Inc. earnings per share (EPS): questions and answers

What is Compass Therapeutics, Inc.'s diluted earnings per share?

Compass Therapeutics, Inc. (CMPX) reported diluted earnings per share of -$0.42 in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$0.36.

What are the highest and lowest diluted earnings per share figures on record for Compass Therapeutics, Inc.?

Across the 4 fiscal years on record (2022–2025), the highest was -$0.33 in fiscal 2023 and the lowest -$0.42 in fiscal 2025.

How is Compass Therapeutics, Inc.'s diluted earnings per share calculated?

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits. For Compass Therapeutics, Inc. it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Compass Therapeutics, Inc. (CMPX) earnings per share (EPS)”, data as of 18 November 2026. https://funkfolio.com/stock/CMPX/eps

Underlying data: the company's filings with the SEC and Yahoo Finance.